Related Experiment Video
Updated: Jul 6, 2026

Radiosynthesis, Quality Control, and Small Animal Positron Emission Tomography Imaging of 68Ga-Labelled Nano Molecules
Published on: October 4, 2024
Recent developments in urologic oncology: positron emission tomography molecular imaging
Kirsten Bouchelouche1, Peter Oehr
1PET & Cyclotron Unit, Department of Nuclear Medicine, Odense University Hospital, Odense, Denmark. bouchelouche@mail.tele.dk
Positron emission tomography (PET) with new tracers enhances uro-oncology imaging for prostate, bladder, and renal cancers. These advancements improve cancer detection, staging, and follow-up, expanding the utility of molecular imaging in urologic oncology.
Area of Science:
- Urologic Oncology
- Molecular Imaging
- Radiochemistry
Background:
- Morphological imaging is standard in uro-oncology.
- Functional and molecular imaging, particularly PET, are increasingly important.
- Recent advancements focus on novel radiotracers.
Purpose of the Study:
- To review recent developments in PET imaging for uro-oncology.
- To highlight the utility of new PET tracers in various urologic cancers.
- To assess the impact of molecular imaging on cancer management.
Main Methods:
- Review of recent literature on PET imaging in uro-oncology.
- Focus on novel radiotracers like 11C-choline, 18F-fluorocholine, 11C-acetate, 18F-fluoride, 18F-FDG, and 124I-cG250.
- Evaluation of PET applications in prostate, bladder, renal, and testicular cancers.
Main Results:
- PET with 11C-choline, 18F-fluorocholine, and 11C-acetate shows promise for prostate cancer.
- 18F-fluoride PET aids in detecting bone metastases.
- 18F-FDG PET/CT may improve detection of recurrent bladder tumors, and both 18F-FDG and 11C-choline PET are useful for staging.
- 18F-FDG PET is valuable for renal cancer staging/restaging, with 124I-cG250 PET showing promise for clear-cell renal carcinoma.
- 18F-FDG PET is useful for staging and follow-up of testicular cancer.
Conclusions:
- New metabolic PET tracers with improved properties have expanded the utility of molecular imaging in uro-oncology.
- PET imaging offers significant advancements in the diagnosis and management of urologic malignancies.
- Continued research into novel radiotracers will further refine PET's role in uro-oncology.
More Related Videos
06:54MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
Published on: September 3, 2013
06:51Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
Related Concept Videos
Positron Emission Tomography
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body being...
Imaging Studies II: Positron Emission Tomography and Scintigraphy
Fundamental Principles of PET
Imaging Studies IV: Magnetic Resonance Imaging
Radiological Investigation III: Pulmonary Angiogram and PET Scan
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
Imaging Studies III: Computed Tomography
Imaging Studies V: Intravenous Urography and Retrograde Pyelography